The expansion of adult stem/progenitor cells and their marker expression fluctuations are linked with pituitary plastic adaptation during gestation and lactancy by Vaca, Alicia Maldré del Valle et al.
The expansion of adult stem/progenitor cells and their marker expression
fluctuations are linked with pituitary plastic adaptation during gestation
and lactancy
Alicia Maldré Vaca,1 Carolina Beatriz Guido,1 Liliana del Valle Sosa,1 Juan Pablo Nicola,2 Jorge Mukdsi,1
Juan Pablo Petiti,1 and Alicia Ines Torres1
1Centro de Microscopía Electrónica, Instituto de Investigaciones en Ciencias de la Salud-Consejo Nacional de
Investigaciones Científicas y Técnicas (CONICET), Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Haya
de la Torre Esq. Enrique Barros, Ciudad Universitaria, Córdoba, Argentina; and 2Centro de Investigaciones en Bioquímica
Clínica e Inmunología, Centro de Investigaciones en Bioquímica Clínica e Inmunología-CONICET, Facultad de Ciencias
Químicas, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende, Ciudad Universitaria, Córdoba, Argentina
Submitted 29 February 2016; accepted in final form 10 June 2016
Vaca AM, Guido CB, Sosa LD, Nicola JP, Mukdsi J, Petiti
JP, Torres AI. The expansion of adult stem/progenitor cells and
their marker expression fluctuations are linked with pituitary plas-
tic adaptation during gestation and lactancy. Am J Physiol Endo-
crinol Metab 311: E367–E379, 2016. First published June 14, 2016;
doi:10.1152/ajpendo.00077.2016.—Extensive evidence has revealed
variations in the number of hormone-producing cells in the pituitary
gland, which occur under physiological conditions such as gestation
and lactancy. It has been proposed that new hormone-producing cells
differentiate from stem cells. However, exactly how and when this
takes place is not clear. In this work, we used immunoelectron
microscopy to identify adult pituitary stem/progenitor cells (SC/P)
localized in the marginal zone (MZ), and additionally, we detected
GFRa2-, Sox2-, and Sox9-positive cells in the adenoparenchyma (AP)
by fluorescence microscopy. Then, we evaluated fluctuations of SC/P
mRNA and protein level markers in MZ and AP during gestation and
lactancy. An upregulation in stemness markers was shown at term of
gestation (AT) in MZ, whereas there were more progenitor cell
markers in the middle of gestation and active lactancy. Concerning
committed cell markers, we detected a rise in AP at beginning of
lactancy (d1L). We performed a BrdU uptake analysis in MZ and AP
cells. The highest level of BrdU uptake was observed in MZ AT cells,
whereas in AP this was detected in d1L, followed by a decrease in
both the MZ and AP. Finally, we detected double immunostaining for
BrdU-GFRa2 in MZ AT cells and BrdU-Sox9 in the AP d1L cells.
Taken together, we hypothesize that the expansion of the SC/P niche
took place mainly in MZ from pituitary rats in AT and d1L. These
results suggest that the SC niche actively participates in pituitary
plasticity during these reproductive states, contributing to the origin of
hormone cell populations.
pituitary gland; stem cell/progenitor markers; marginal zone; gesta-
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THE PITUITARY GLAND IS A CENTRAL REGULATOR of growth, repro-
duction, and endocrine physiology and functions by relaying
signals from the hypothalamus to various target organs. Its
major endocrine function resides in the pars distalis (PD),
which contains five different specialized hormone-producing
cell types whose proportions can alter under different physio-
logical conditions (31), such as the reproductive cycle (23),
gestation, and lactancy (22, 47). This hormone output must be
fine-tuned and adapt swiftly to changing needs, thereby requir-
ing dynamic and accurate functional and quantitative remod-
eling of the hormonal cells (36, 45). It has been described that
the generation of new endocrine cells occurs in different ways,
including the mitosis of already differentiated cells (10, 37),
transdifferentiation between distinct cell phenotypes (40, 50),
and differentiation of stem/progenitor cells (8). All three pro-
cesses combine their effects in dynamic cell adaptations, but a
single mechanism may predominate depending on the partic-
ular physiological situation. The plasticity of the pituitary
gland is in fact one of the most important features that allows
the existence of stem cells (SC) to be postulated in this adult
endocrine tissue (39).
The development of the pituitary gland begins with a struc-
ture called Rathke’s pouch, which invaginates from the oral
ectoderm and grows out around the remaining lumen-denom-
inated cleft. Embryonic progenitor cells appear to reside in the
marginal zone (MZ) around the cleft. Indeed, cells in this zone
markedly proliferate and ostensibly migrate to the emergent
PD, where they develop further into different hormonal cell
lineages (27). During postnatal life, multilayered and heter-
ogeneous MZ cells, referred to as the niche for putative
pituitary SC, are able to retain some features of their
embryonic nature (49).
The SC have been reported in different adult organs on the
basis of their capacity to proliferate and carry out self-renewal,
a differentiation potential, and the ability to regenerate tissue
after cell loss and are able to express key marker genes (32, 35,
41), with the principal ones being the transcription factors
Oct-4 and Sox2, which are involved in the maintenance of
pluripotency in the genome of SC (48, 55). The Sox9 progen-
itor marker, a member of the SoxE subfamily, is important in
embryonic and postnatal development (9) and participates in
differentiation programs by activation of tissue-specific genes
(26). In the pituitary gland, it has been postulated that the
transcription factor Prop1 might play a role as a trigger in the
terminal differentiation process of progenitor cells, leading to
the development of endocrine cells (53, 54). Prop1 positively
regulates the expression of the pituitary-specific transcription
factor Pit-1, with this factor being critical for normal thyro-
troph, somatotroph, and lactotroph development. Furthermore,
Prop1 and Pit-1 have been associated with the maturation of
committed cell lineages (28, 44).
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Several nonendocrine cells have been described as being SC
and proposed to maintain pituitary homeostasis by the gener-
ation of new endocrine cells. Nevertheless, the identity and
functional position of adult pituitary SC and their role in the
pituitary plasticity described in physiological conditions are
not well understood. Numerous studies have been able to
demonstrate that these nonendocrine cells in the adult pituitary
gland express stemness markers; for example, a side popula-
tion that efficiently excludes the Hoechst 33342 vital dye has
been shown to generate sphere-forming cells (8). Also, pitu-
itary colony-forming cells that display a notable clonal poten-
tial have been isolated (30). However, the only common
marker studied for these cells was Sca1, and to date its position
in the pituitary is not well established. The presence of Sox2
and Sox9 cells in the MZ and clusters scattering in the
adenoparenchyma (AP) have allowed these transcription fac-
tors to be proposed as markers of pituitary SC/progenitors
(SC/P) or transit-amplifying cells (15, 58). In addition, a niche
of putative SC/P in the pituitary expresses the Glial cell
line-derived neurotropic factor receptor-2 (GFRa2), with this
specific marker proposed for pituitary SC being localized in
MZ cells (19) and recently detected in scarce AP cells (18).
Extensive evidence has revealed significant changes in the
number of different PD cell populations in certain defined
physiological conditions to meet the endocrine demands of the
organism (3), with an increased mitotic activity of lactotrophs
being reported during the reproductive cycle and lactancy (2,
38). However, exactly how and when this takes place is not
clear. It has been proposed that during plastic adaptations and
basic cell turnover, new hormone-producing cells differentiate
from nonendocrine cells, which represent SC (36). Therefore,
gestation and lactancy represent an adequate physiological
model to test cell differentiation of potential SC. In an attempt
to elucidate this mechanism, we identified the SC/P in the
pituitary gland by fluorescence and electron microscopy and
evaluated the possible changes in SC/P-associated markers
expressed in the MZ and the adenoparenchyma during gesta-
tion and lactancy. Furthermore, the specific contribution of
these cells in the maintenance of pituitary homeostasis in
response to physiological hormonal requirements was also
analyzed.
MATERIALS AND METHODS
Animals and experimental design. Virgin female Wistar rats aged
10–12 wk were examined by vaginal smear cytology and assigned to
the estrous or diestrous II phases. Only rats that completed the estrous
phases over two cycles were included in this study. Rats were mated
with proven fertile males and then divided in the following groups:
group A [gestation (G)], i.e., copula (COP), rats in the estrous phase
that had sperm in their vaginal smear at 5 days of gestation after
copula (d5G), at 15 days after copula (d15G), and at term of gestation
(AT); and group B [lactancy (L)], i.e., pregnant rats that were
transferred to individual cages until the day of parturition. At birth, the
number of litters was adjusted to eight pups, and then the mothers
were euthanized at the beginning of lactancy (d1L or early lactancy)
or after 4 days of lactancy (d4L or active lactancy).
All rats were bred and housed at the Animal Research Facility of
the INICSA-CONICET-School of Medicine, National University of
Córdoba, under controlled temperature (21  3°C) and lighting
conditions (14:10-h light-dark cycle), having free access to commer-
cial rodent food and tap water. Animals were kept in accordance with
the National Institutes of Health Guide for the Care and Use of
Laboratory Animals (1996), and the experiments were approved by
the Institutional Animal Care Committee of School of Medicine,
National University of Córdoba.
Characterization of cells in the MZ by high-resolution light mi-
croscopy, transmission electron microscopy, and ultrastructural
immunocytochemistry. MZ cells were studied in three hemipituitaries
from each experimental group after being fixed by immersion in 4%
(vol/vol) glutaraldehyde and 4% (wt/vol) formaldehyde in 0.1 M
cacodylate buffer, treated with 1% osmium tetroxide (Sigma, St.
Louis, MO), dehydrated, and embedded in Araldite (Electron Micros-
copy, Hatfield, PA). For high-resolution light microscopy analysis,
semithin (200 m) sections were stained with blue toluidine, and MZ
cells were observed. The MZ cell ultrastructures were analyzed in thin
sections (60 m), stained with uranyl acetate/lead citrate, and exam-
ined in a Zeiss-Leo 906-E electron microscope.
For ultrastructural immunocytochemistry (UICC), the animals of
each group were euthanized by decapitation, and pituitary glands were
removed and cut into two small pieces in coronal orientation. Then,
these glands were fixed for 4 h in 4% (wt/vol) formaldehyde with
0.75% (vol/vol) glutaraldehyde in 0.1 M cacodylate buffer. The fixed
tissues were dehydrated by a series of increasing concentrations of
ethanol and immersed in LR White (Electron Microscopy) before
being embedded in gelatin capsules to avoid contact of the resin with
oxygen. The ultrathin sections were cut and placed on nickel grids.
The method of UICC used was described previously (12). Briefly,
sections were incubated with blocking solution composed of the three
proteins, 5% bovine serum albumin (BSA), 5% goat normal serum,
and 1% cold fish skin gelatin, and then reacted with anti-vimentin
(mouse 1:100 Novocastra), anti-GFRa2 (rabbit, 1:100; Santa Cruz
Biotechnology, Dallas, TX), anti-Sox2 (rabbit, 1:50; Millipore, Bil-
lerica, MA), anti-Sox9 (mouse, 1:100; Santa Cruz Biotechnology), or
anti-Oct-4 (rabbit, 1/50; Santa Cruz Biotechnology) as the primary
antiserum. Then, they were exposed to goat anti-mouse or anti-rabbit
IgG labeled with a 15-nm gold complex (1:30; Electron Microscopy).
The grids were stained with uranyl acetate (Sigma) and examined
using a Zeiss LEO 906-E electron microscope. To validate the
specificity of the immunostaining, we performed a negative control,
replacing the primary antiserum with 1% BSA in PBS followed by the
secondary antibody.
Ultrastructural morphometric analysis was performed on electron
micrographs obtained from coronal sections of two different MZ areas
separated from each other by 50 m in all of the experimental groups.
To avoid duplicate counting of the same cell, only one large section
from each block was mounted on a 200-mesh nickel grid. Then, 100
electron micrographs were taken randomly from each section at a
magnification of 16,700, covering 100 –200 cells/animal. Using
ImageJ 1.47v (Wayne Rasband; National Institutes of Health), we
counted all gold particles in the cytoplasm and the nucleus com-
partment per area unit, named labeling density (11). The number of
gold particles was referenced to 10 m2 of cytoplasm or nucleus
compartment.
BrdU uptake in AP and MZ cells. 5-Bromo-2=-deoxiuridina (BrdU;
Sigma), which is incorporated in DNA instead of thymidine in cells in
the S phase of the cell cycle, was dissolved in phosphate-buffered
saline (PBS; 50 mg/ml) and injected intraperitoneally at a dose of 50
g/g rat weight 12 h before decapitation.
Four pituitary glands per experimental group were fixed in 4%
buffered formaldehyde, dehydrated, and embedded in paraffin. These
pituitaries were then cut, deparaffined, rehydrated, and washed in 0.1
M PBS before being treated with 3% H2O2 for 15 min to inhibit
endogenous peroxidase activity, after which 5% PBS-BSA was ap-
plied for 30 min to block nonspecific binding of the secondary
antibody. Pituitary sections were incubated overnight in a 1:100
solution containing anti-BrdU (GE Healthcare Life Sciences), and
then the slides were washed with PBS and exposed to a biotin-labeled
secondary antibody against mouse IgG at room temperature for 30
min and to ABC complex for 30 min (Vector Laboratories, Burlin-
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game, CA). Subsequently, the slides were immersed in a solution
containing 3-3=-diaminobenzidine (Sigma) in 0.1 M Tris buffer, pH
7.2, containing 0.03% H2O2 before being counterstained with hema-
toxylin, dehydrated, and cover-slipped with mounting liquid (Sigma).
Negative controls were also performed by applying the same protocol,
but BrdU antibody was omitted.
Three different levels from the coronal pituitary sections, including
MZ and AP, which were separated from each other by 50 m, were
sampled per rat and used for morphometric analysis. All results were
pooled for each individual animal. Immunoreactive cells were ob-
served using a light microscope at a magnification of 400, with the
number of BrdU -mmunoreactive cells being counted from two MZ
layers and from a total of 5,000 AP cells obtained from random
samples taken from each rat.
Immunodetection of SC/P markers and BrdU incorporation in
frozen pituitary gland samples. The pituitary gland of the different
experimental groups studied were placed in Crioplast (Biopack, Bue-
nos Aires, Argentina) and immersed in liquid nitrogen for a few
minutes until the solidification of the embedding medium and stored
at 80°C. For immunodetections, the cryostat sections were fixed in
absolute methanol, incubated with PBS-BSA 5%, and then reacted
with anti-GFRa2 (rabbit, 1:100; Santa Cruz Biotechnology), anti-
Sox2 (mouse, 1:200; Millipore), anti-Sox9 (rabbit, 1:200; Santa Cruz
Biotechnology), or anti-BrdU (mouse, 1:100; GE Bioscience Health-
care). Subsequently, the slides were exposed to a secondary antibody
Alexa 594 anti-rabbit (1:1,000; Invitrogen, Carlsbad, CA) or anti-
mouse Alexa 488 (1:1,000; Invitrogen, Eugene, OR) for 1 h at room
temperature and mounted with fluoromount (Sigma) containing DAPI.
For double immunodetection, analysis was performed on consec-
utive days to avoid nonspecific immunolabeling given by the second-
ary antibody. Briefly, during the 1st day, samples were incubated with
BrdU (mouse, 1:100), GFRa2 (rabbit, 1:100), Sox9 (rabbit, 1:200), or
prolactin (PRL; rabbit 1:10,000; National Hormone and Pituitary
Program, Torrance, CA) antibodies. Then they were washed with PBS
and exposed to a secondary antibody labeled with Alexa 594 (1/
1,000). On the 2nd day, the samples were washed with PBS and
incubated with BrdU. Then they were reacted with secondary anti-
body Alexa 488 (1:1,000). To validate the specificity of the immuno-
staining, negative controls were performed by applying the same
protocol but replacing primary antibody with 5% PBS-BSA.
Laser capture microdissection and RNA isolation. The pituitary
glands of rats corresponding to the G and L groups were immersed in
buffer solution with 0.1 M Tris, zinc salts (5 g of ZnCl2, 6 g of
ZnAc2.2 H2O, and 0.1 g of CaAc2), and 30% sucrose and then frozen
in tissue-freezing medium (Crioplast; Biopack, Buenos Aires, Argen-
tina). These samples were cut into 15-m sections using a cryostat
(Shandon Cryotome SME), transferred to polyethylene naphthalate
membrane, fixed in 70% ethanol at 20°C, and dehydrated on
activated silica. MZ and AP regions were morphologically identified
and captured using laser dissection microscopy (Leica LDM6000).
Dissected areas were collected, and the total RNA was isolated using
an illustra RNAspin Mini RNA Isolation Kit (GE Healthcare Life
Sciences), following the manufacturer’s recommendations.
Complementary DNA synthesis was performed by incubating 11
l of total RNA extracted from MZ and AP regions with 9 l of
reverse-transcription reaction mixture containing 4 l of FS buffer
(5), 1 l of dNTPs (10 mM), 1 l of random hexamers (50–250 ng),
1 l of M-MLV reverse transcriptase (200 U/l), 0.5 l of RNase out
(40 U/l), and 1.5 l of DTT (0.1 M). Reverse-transcription reaction
was performed on a 5332 Eppendorf Mastercycler using the following
temperature cycle: 10 min at 70°C, 1 min on ice, 10 min at 25°C, 1 h
at 37°C, and 15 min at 70°C.
Gene expression analysis by quantitative PCR. Real-time PCR
analysis was performed on an ABI Prism 7500 detection system
(Applied Biosystems, Foster City, CA) using Power SYBR Green
PCR Master Mix (Applied Biosystems, Thermo Fisher Scientific,
Waltham, MA). The gene-specific primer sets are described in Table
1. Relative changes in gene expression were calculated using the
2CT method normalized against the housekeeping gene 	-actin.
For each pair of primers, a dissociation plot resulted in a single peak,
indicating that only one cDNA species was amplified. Amplification
efficiency for each pair of primers was calculated using standard
curves generated by serial dilutions of cDNA obtained from embryos
at 10 wk of gestation. All primers were from GBT Oligos Genbiotech
(Buenos Aires, Argentina).
Statistical analysis. Statistical analysis was carried out using an
analysis of variance with the Tukey posttest (SPSS Statistics for
Windows, version 17.0). The results are given as means  SE, and the
data were obtained from three replicates measured for three indepen-
dent experiments. The significance level chosen was P 
 0.05.
RESULTS
Characterization and topographic localization of the SC
niche in the MZ. First, we attempted to localize topographically
the MZ and study the morphology of the cells sited in this area
by high-resolution light and electron microscopy. The MZ is
composed of two layers of cells (Fig. 1), with one of these
outlining the cleft and the other situated below in tight contact.
The cells that composed the first layer of the MZ had in general
a cuboid appearance with an increased nucleus/cytoplasm re-
lationship and an absence of secretory granules in the cyto-
plasm. Some of these cells possessed apical extensions such as
cilia and microvilli, which are hallmarks associated with the
SC phenotype, and the cells that presented microvilli and cilia
Table 1. Oligonucleotide primers and expected amplicon sizes for qPCR amplification of the markers analyzed
Marker Nucleotide Sequence Genebank Accession No. (Position of Amplified Fragment)
Oct-4 Forward: 5=-ACACCTGGCTTCAGCTTCG-3= NM_001009178 (89–448)
Reverse: 5=-CAGAGTCTCCACGCCAACTT-3=
Sox2 Forward:5=-CTCTGTGGTCAAGTCCGAGG-3= NM_001109181 (1,092–1,379)
Reverse: 5=-CTCTTTTGCACCCCTCCCAA-3=
Sox9 Forward: 5=-TGAAGATGACCGACGAGCAG-3= XM_003750950 (406–676)
Reverse: 5=-GTGTGGCTTGTTCTTGCTGG-3=
GFRa2 Forward: 5=-TCAGGGACTTCACGGAAAAC-3= NM_012750 (1,136–1,332)
Reverse: 5=-AGATGTGCAGGTGGTGATGA-3=
Prop1 Forward: 5=-AGTCAGCCTTTGGGAGGAAC-3= NM_153627 (248–368)
Reverse: 5=-TAGTGACCGCTCTTGCTTCC-3=
Pit-1 Forward:5=-GGAGAGCACAGCAAACCTTC-3= L01506 (748–980)
Reverse: 5=-ATGGCTACCACAGGCAAGTC-3=
-actina Forward: 5=-ACCCACACTGTGCCCATCTA-3= NM_031144 (556–845)
Reverse: 5=-CGGAACCGCTCATTGCC-3=
qPCR, quantitative PCR; GFRa2, glial cell line-derived neurotropic factor receptor-2.
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in the apical membrane were oriented toward the cleft (Fig. 2).
The second MZ layer is composed of cells with similar mor-
phological characteristics described for SC and others with a
fusiform shape similar to supporting cells referred to as mes-
enchymal cells (MC).
To characterize completely the SC niche, we identified a
marker of supporting MC such as vimentin by UICC. Vimentin
expression was observed in MZ cells, being dispersed in the
cytoplasm and unassociated with the organelles. These vimen-
tin-positive cells were arranged below the first line MZ cells
(Fig. 3, A and B).
Subcellular localization of markers associated with the SC/P
phenotype. Subcellular localization and the distribution of
markers associated with the SC/P phenotype at the MZ of adult
pituitaries were analyzed by UICC. The expression of Oct-4
and GFRa2 was intense in cells localized at the region around
the cleft, which then decreased toward the adenohypophysis. In
particular, the GFRa2 expression was dispersed in the cyto-
plasm of cells localized in the first layer of the MZ (Fig. 4A),
with Oct-4 being observed in the nucleus and cytoplasm of
these cells (Fig. 4B). In addition, both SC markers were
observed in cells with apical membrane differentiations. The
expression of Sox2 and Sox9 was observed in the first line of
MZ cells and also in cells with morphological SC characteris-
tics that composed the second MZ line. An interesting obser-
vation was that Sox2 had a remarkable immumoreactivity
within the nucleus of MZ cells. Meanwhile, Sox9 immunogold
labeling was weaker in the nucleus and cytoplasm of cells
localized in this zone (Fig. 4, C and D).
In parallel, we performed assays using immunofluorescence
microscopy to search for and identify GFRa2-, Sox2-, or
Sox9-positive cells in the adult pituitary gland. As shown in
Fig. 4, E and F, we observed GFRa2- and Sox2-positive cells,
respectively, in the AP as a few sparse cells, whereas Sox9-
positive cells were observed to be scattered in AP and are
displayed in Fig. 4G.
Analysis of mRNA levels of SC/P and committed cell mark-
ers in the MZ and adenoparenchyma during gestation and
lactancy. To assess whether the stemness, progenitor markers,
and gene expression associated with committed cells exhibited
any changes in the MZ and AP during the reproductive states
under study, we used laser capture microdissection to individ-
ually isolate each zone. Total RNA was isolated and the
mRNA expression of marker genes evaluated by real-time
PCR.
Gene expression in the MZ. The mRNA levels of the SC
markers GFRa2, Sox2, and Oct-4 exhibited the highest expres-
sion at the end of gestation (AT) compared with their expres-
sion at earlier gestation stages. Moreover, we observed a
significant decrease in the expression of these markers during
lactancy (Fig. 5A1). The progenitor gen marker Sox9 displayed
Fig. 1. Topographic localization of the marginal zone (MZ) in the adult
pituitary gland. The gland has 3 regions: the pars distalis (PD) containing the
epithelial endocrine cells and the MZ (indicated by the dotted line) outlining
the cleft that comprises the 1st and 2nd layers of cells from the PD, the pars
nervosa (PN) comprising axon terminals and supportive pituicytes, and the
pars intermedia (PI) containing melanocortin cells. Inset shows in detail the
apical extensions of a cell located in the MZ. Original magnification, 400;
inset, 1,000.
Fig. 2. The MZ in the adult pituitary gland. A: electron micrograph of a pituitary gland section from an adult rat reveals the fine structure of cells located in the
MZ (indicated by the dotted line). Some MZ cells of the 1st layer identified as stem cells (SC) have apical extensions such as cilia and microvilli. Below this
layer there are some cells having a fusiform shape, with this morphology being compatible with mesenchymal cells (MC). Original magnification, 2,100. B:
representative micrograph of typical ultrastructural characteristics of cilia. Arrowheads indicate basal bodies. *Axonema. Original magnification, 6,000.
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a different expression pattern during the reproductive stages,
showing a twofold increase at d15G before returning to basal
levels at term of gestation but exhibiting a significant increase
at 4 days of active lactancy (Fig. 5A2). The expression of the
lineage-committed markers Prop1 and Pit-1 did not exhibit any
significant variations during gestation. Nevertheless, we ob-
served a significant increase in the expression levels of Prop1
and Pit-1 at AT and early lactancy compared with their ex-
pression during gestation (Fig. 5A3).
Gene expression in the adenoparenchyma. The GFRa2,
Oct-4, and Sox2 mRNA levels showed a significant reduction
at d5G and d15G with respect to COP, although Oct-4 mRNA
exhibited an increase at AT. The lactancy stimuli induced a
striking rise in GFRa2 mRNA levels but a significant reduction
in the Sox2 and Oct-4 mRNA levels (Fig. 5B1). Conversely,
Sox9 mRNA levels did not show significant variations during
gestation and lactancy stages (Fig. 5B2).
For the period of gestation, the mRNA levels of the lineage-
committed marker Prop1 did not show a significant modifica-
tion. Meanwhile, Pit-1 mRNA expression showed a significant
increase at d15G and AT. In addition, at early lactancy, Prop1
and Pit-1 mRNA displayed a significant increase. However,
after 4 days of lactancy, Prop1 mRNA levels decrease and
Pit-1 return to AT levels (Fig. 5B3). In addition, we ana-
lyzed the relationship between Pit-1/Prop1 in MZ vs. AP. In
MZ, Prop1 expression was greater than Pit-1 in AT (0.69 
0.085) and d1L (0.70  0.058), whereas this relation was
inverted (P 
 0.05) in AP of the same groups (AT: 1.81 
0.14; d1L: 1.70  0.23).
Expression of SC/P markers in MZ cells during gestation
and lactancy. To evaluate the expression of the SC/P markers
GFRa2, Oct-4, Sox2, and Sox9 in MZ cells throughout differ-
ent reproductive states such as gestation and lactancy, we
quantified the immunogold labeling using an electron mi-
croscope. This technique is a reliable tool and allowed us to
quantify the markers of SC/P cells localized specifically in
MZ and to determine their possible fluctuations in response
to changes in hormonal surges during physiological condi-
tions.
GFRa2. GFRa2 expression in the cytoplasm of MZ cells
quantified by morphometric analysis was similar at COP and
d5G. However, there was a marked reduction in the middle of
the gestation (d15G) compared with COP (P 
 0.05) but a
noticeable increase at term of gestation. At the beginning of
lactancy, the GFRa2 expression revealed a significant decrease
(P 
 0.05 vs. AT), with this level maintained after 4 days of
lactancy (Fig. 6A).
Oct-4 and Sox2. The Oct-4 expression quantified in the
cytoplasmic compartment of the MZ cells was similar at COP
and gestation (d5G, d15G). In contrast, the immunolabeled
nuclear Oct-4 exhibited a significant decrease in the middle of
gestation and at AT. During active lactancy (d4L), the nuclear
and cytoplasmic Oct-4 expression showed a great increase
compared with at AT (P 
 0.01), but no significant differences
between nuclear and cytoplasmic compartments were observed
at COP, gestation, or early lactancy. However, in d4L, the
immunolabeled Oct-4 revealed a different subcellular distribu-
tion, as a higher expression in the cytoplasm than in the nuclear
compartment was observed (Fig. 6B).
The Sox2 expression exhibited a different subcellular distri-
bution pattern, displaying higher levels in the nuclear com-
pared with the cytoplasmic compartment at COP and d15G
(COP CC vs. NC, P 
 0.05, and d15G CC vs. NC, P 
 0.01).
During active lactancy, the expression of this marker in both
subcellular compartments showed remarkable increases (d4L
vs. AT, P 
 0.01; Fig. 6C).
Sox9. The Sox9 expression was analyzed in both the nuclear
and cytoplasmic compartments of cells localized in MZ during
the gestation and lactancy groups. The morphometric study
showed a significant decrease in Sox9 immunolabeled
within the cytoplasmic compartment during gestation at d5G
and d15G compared with at COP, with a noticeable dimi-
Fig. 3. The ultrastructural localization of MC was examined in pituitary glands of adult rats by vimentin ultrastructural immunocytochemistry. A: representative
micrograph of a vimentin-positive cell localized in the 2nd layer of the MZ below a cell with apical extensions. B: cytoplasm observed in the 2nd MZ layer is
an extension of the cell exhibited in A, showing vimentin-positive expression. Dotted line indicates the limit between the 1st and the 2nd layer of MZ. Original
magnification, 16,700.
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nution also being observed in the d5G nuclear expression
(P 
 0.05 vs. COP) of this marker. However, this subcel-
lular compartment displayed a significant increase at AT
with respect to COP.
At early lactancy (d1L), the Sox9 expression determined in
both subcellular compartments of MZ cells exhibited a remark-
able increase compared with AT (P 
 0.01 vs. AT) but decreased
significantly after 4 days of active lactancy (Fig. 6D).
Fig. 4. Immunodetection of stem/progenitor cell (SC/P) markers in the MZ and adenoparenchyma (AP) of adult rat pituitary glands by electron and fluorescence
microscopy. A: immunoelectron micrographs of Glial cell line-derived neurotropic factor (GDNF) receptor-2 (GFRa2) cell localized in the 1st MZ layer
displaying cilia at the apical membrane. Dotted square shows the location of the inset zone. The GFRa2 cell exhibits moderate immunoreactivity in the
cytoplasm near the plasma membrane. Original magnification, 10,000. B: Oct-4 cell identified by ultrastructural immunocytochemistry exhibiting microvilli
in the apical membrane is situated in the 1st MZ layer. Immunogold labeling is intense at the cytoplasm. C: nucleus of the Sox2 cell exhibits a stronger
immunoreactivity than that observed in the cytoplasmic matrix using the colloidal gold technique. D: immunopositive MZ cell for Sox9 shows a free cytoplasmic
labeling. Original magnification B–D, insets: 16,700, with 15-nm gold particle identified by arrows. E: MZ cells (white dotted circle) and clusters cells in the
adenoparenchyma exhibited the expression of the GFRa2 marker (white arrowheads). Dotted line indicates the MZ. Original magnification, 200. Inset: *some
cells of the MZ expressing the GFRa2 receptor on the surface. Original magnification, 400. F: *scarce cells of the AP expressed Sox2 in the cytoplasm. Original
magnification, 400. G: scattered cells in the AP showed expression of Sox9. Original magnification, 200.
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Cell proliferation in the MZ and adenoparenchyma during
gestation and lactancy. To investigate a possible link between
the SC/progenitor/committed marker variations and the MZ
and AP cell proliferation during gestation and active lac-
tancy, we analyzed the uptake of BrdU into the nucleus of
these cells.
Marginal cell proliferation. The uptake of BrdU of MZ
cells displayed a dynamic fluctuation during gestation and
lactancy, with COP considered to be the starting point
(4.48  0.37%). At 5 and 15 days of gestation, we observed
a twofold decrease in BrdU-positive MZ cells (P 
 0.01 vs.
COP), with the highest levels of MZ cell proliferation being
recorded in the AT (10.15  0.49%). The beginning of
lactancy, d1L, revealed a significant reduction in BrdU-
positive cells with respect to AT, which after 4 days of
active lactancy had reached a fivefold decrease with respect
to d1L (5.63  0.21 and 1.06  0.10%, respectively; Fig.
7F). Interestingly, more BrdU-immunopositive cells were
observed in the first layer of MZ than in the second one (Fig.
7, A–E).
Adenoparenchyma cell proliferation. The number of BrdU-
immunopositive AP cells was significantly higher at d5G
than at COP (3.20  0.05 and 2.29  0.02%, respectively),
with a significant decrease at term of gestation resulting in
values similar to those at COP. In the early lactancy group,
the proliferation of adenohypophysial cells showed a rise of
1.5-fold with respect to the values quantified at AT (3.59 
0.3 and 2.29  0.09%, respectively), followed by a decrease
of about eightfold at d4L (0.46  0.07%) (Fig. 8, A–F).
Coimmunodetection of BrdU with GFRa2 or Sox9
expression. Finally, we carried out a double-immunofluores-
cence assay for BrdU uptake and GFRa2, a pituitary-specific
SC marker that exhibited a high expression in the AT group,
in which the BrdU incorporation peak was observed in the
MZ. As shown in Fig. 9, A and B, the coimmunodetection
for BrdU and GFRa2 in MZ cells was more evident in the
AT group, attaining a twofold increase compared with the
COP group (2.36  0.72 and 0.29  0.29%, respectively;
Fig. 9C).
Bearing in mind that in the AP the highest cell proliferation
values were observed in early lactancy and that Sox9 partici-
pated in the expansion of the progenitor cell population, we
compared the percentage of BrdU- and Sox9-positive cells in
AP vs. MZ (Fig. 9, D and E) and found that the number of
BrdU-positive cells that expressed the Sox9 marker was sig-
nificantly greater in the AP than the MZ in the d1L group
(3.06  0.43 vs. 1.22  0.23%, respectively). In addition, we
carried out a double-immunofluorescence assay for Sox9 and
PRL, the main hormone expressed during lactancy. As shown
in the Fig. 9F, only a few cells coexpressed Sox9 and PRL in
the AP of the d1L.
Fig. 5. Relative evaluation of SC/progenitor/committed mRNA levels in MZ and AP from gestation and lactancy pituitaries. A1–A3: GFRa2, Oct-4, Sox2, Sox9,
Prop1, and Pit-1 mRNA levels quantified in MZ. A1: GFRa2 [*P 
 0.05 AT vs. copula (COP)], Oct-4 (ŒP 
 0.05 AT vs. COP), and Sox2 ({P 
 0.05 AT vs.
COP) show an increase at term of gestation but a decrease during lactancy [GFRa2: ŒP 
 0.05 beginning of lactancy (d1L) and 4 days of lactancy (d4L) vs.
AT; Oct-4: P 
 0.05 d1L and d4L vs. AT; Sox2: P 
 0.05 d1L and d4L vs. AT]. A2: Sox9 increased at d15G and d4L (*P 
 0.05 d15G vs. COP; ŒP 

0.05 d4L vs. AT). A3: Prop1 and Pit-1 show the highest levels at AT and early lactancy (*P 
 0.05 AT vs. COP; ŒP 
 0.05 d1L vs. COP). B1–B3: GFRa2,
Oct-4, Sox2, Sox9, Prop1 and Pit-1 mRNA levels quantified in AP. B1: SC markers decrease during gestation (GFRa2: *P 
 0.05, d5G, d15G, and AT vs. COP;
Oct-4: oP 
 0.05, d5G and d15G vs. COP; Sox2: {P 
 0.05 d5G and d15G vs. COP). However, in AT rats, Oct-4 mRNA exhibits an increase with respect
to at COP (ŒP 
 0.05, AT vs. COP). The GFRa2 shows the highest levels at d1L (ŒP 
 0.05, d1L vs. AT), whereas Sox2 does not evidence any significant
changes in all groups analyzed. B2: Sox9 progenitor marker does not exhibit any variations during gestation or lactancy. B3: Pit-1 levels show increase from
the middle of gestation to early lactancy (P 
 0.05 d15G and AT vs. COP; P 
 0.05 d1L vs. AT), whereas Prop1 exhibits an increase at d1L (ŒP 
 0.05
d1L vs. AT). The mRNA expression was relatively quantified to that of 	-actin. Results are shown as fold change of the mRNA levels for COP and AT groups.
Data are representative of 3 independent experiments and were analyzed by ANOVA-Tukey test.
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In the present study, we have demonstrated the participation
of pituitary SC in the physiological cell turnover from fluctu-
ations in SC/P mRNA and the protein level markers in com-
bination with significant changes in the MZ cell proliferation
rate, which took place during gestation and lactancy. Taking
these findings into consideration, it appears that the SC pitu-
itary niche actively participates in pituitary plasticity during
these reproductive states, thereby being involved in the origin
of mature hormone cell populations.
A stem cell niche is defined not only by the presence of
tissue SC but also by the characterization of somatic support
cells, which secrete essential factors for the maintenance of
pluripotency in resident stem cells (51). An SC niche has been
reported in the pituitary gland based on the detection of SC/P
and mesenchymal cell markers in MZ by immunofluorescence
(15, 19, 42). In the current investigation, we confirmed the
presence of an adult pituitary SC niche and described for the
first time through ultrastructural analyses the organization of
MZ cells into two layers. GFRa2 and Oct-4 were expressed in
the first layer of MZ cells, with some of these cells exhibiting
microvillus and cilia in the apical membrane, thereby suggest-
ing that they maintained the primary cilium as observed pre-
viously in the mitosis of embryonic cells that retained stem cell
features (6). In both MZ layers, we identified Sox2- and
Sox9-immunolabeled cells, whereas the vimentin-supporting
cell marker (33) was visualized only in some cells of the
second layer of this zone, which were precisely localized,
surrounding the first layer of MZ cells. Moreover, in the AP of
the adult pituitary gland, the GFRa2, Sox2, and Sox9 single
positive cells and a few sparsely distributed groups were
observed. In line with these results, it has been reported
recently that scattered cells throughout the AP are positive for
GFRa2 in the adult gland (18) in addition to some other
previously identified SC markers such as Sox2, Sox9, and Klf4
(7, 20). These findings suggest the existence of multiple SC
Fig. 6. Analysis of SC/P marker expression patterns in the cytoplasmic (CC) and nuclear (NC) compartments of the MZ cells. A: GFRa2 expression displays
a remarkable increase at term of gestation. *P 
 0.05, AT vs. COP; P 
 0.05, d15G vs. COP; P 
 0.05, d1L and d4L vs. AT. B: Oct-4 marker shows an
increase in nuclear and cytoplasmic compartments in active lactancy. P 
 0.01, d4L vs. AT; *P 
 0.01, d15G and AT vs. COP (NC). C: a differential Sox2
distribution is exhibited between the nuclear and cytoplasmic compartments at COP (P 
 0.05, NC vs. CC) and d15G ({P 
 0.01 NC vs. CC), whereas in
active lactancy Sox2 is increased in both subcellular compartments P 
 0.01, d4L vs. AT. D: Sox9 marker expression displays an increase at early lactancy
in both the nucleus and cytoplasm. P 
 0.01, d1L vs. AT, with a notable decrease observed at d4L; eP 
 0.05, d4L vs. AT; *P 
 0.05, d5G and d15G vs.
COP (CC); P 
 0.05 d5G vs. COP and }P 
 0.05 AT vs. COP (NC). Results are given as means  SE from 3 independent experiments. The data were analyzed
by the ANOVA-tukey test.
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niches that could be favorable for dynamic and/or subtle cell
adaptations.
A mitotic variability was described in the anterior pituitary
of female rats (38, 56) in the estrous cycle and also during
pregnancy and lactation (5, 13, 14), with estrogen being the
principal cause for the increased lactotroph cell population
(31). Considering the evidence of an SC/P niche in the adult
pituitary and in an attempt to achieve a better understanding of
the new endocrine cell supply during the cell turnover that
occurs in states such as reproduction, we evaluated in vivo the
SC/P contribution to the cell differentiation during gestation
and lactancy. There is consistent evidence that GFRa2 cells
are located in the MZ of the adult pituitary (19), in agreement
with our findings. However, little is known about their partic-
ipation during new endocrine cell production. Our study re-
vealed a noticeable increase in GFRa2 expression in the MZ at
the end of gestation, suggesting its involvement in the SC
recruitment that occurs in the MZ, thus giving rise to a
progenitor cell population. Related to this, a recent report
described that the upregulation of Ret receptor and its core-
ceptors GFRa1, GFRa2, and GFRa3 is key for hematopoietic
SC survival and pluripotency and allows these cells to be
distinguished from progenitor ones in the fetal liver (16). On
the other hand, the greater mRNA GFRa2 expression in AP vs.
MZ may have been related partly to the hormonal fluctuations
that have been widely described in COP and lactation states,
suggesting that the GFRa2 AP cell groups may not represent
isolated focal spots. Therefore, as described previously, the
SC/P AP cell groups may be establishing a three-dimensional
cooperating network throughout the gland, thereby allowing
long-range communication between the stem cells, which
would be important in coordinating their maintenance, prolif-
eration, and differentiation activities (29, 34).
The other principal factors implicated in the maintenance
of pluripotency in adult SC such as Oct-4 and Sox2 exhib-
ited a notable increase in the mRNA levels in the MZ from
the AT pituitary group. In addition, their protein expression
levels showed an important rise in the active lactancy group
(d4L). This dissociation observed between transcription and
translation has also been reported for these markers in other
studies performed at the early stages of the embryonic stem
cell differentiation process, indicating that translational and
posttranslational regulatory mechanisms have important
roles in SC fate decisions and may reflect the nature of a
Fig. 7. Cell proliferation in MZ cells at gestation and lactation pituitaries. A–E: representative light microscope photomicrographs of BrdU-positive cells observed
in rats at COP (A), d5G (representative of gestation; B), AT (C), d1L (D), and d4L (E). Arrows highlight selected cells that are positive for BrdU in the 1st and
2nd ZM layers. Original magnification, 400. F: proportion of BrdU uptake in MZ cells. The BrdU incorporation peak occurs in AT pituitary gland in contrast
with the other experimental groups. The d5G and d15G groups exhibit a decrease in BrdU (*P 
 0.01, d5G and d15G vs. COP) but then a notable rise at AT
(P 
 0.01, AT vs. COP), which is followed by a decrease during lactancy ({P 
 0.01, d1L and d4L vs. AT). The BrdU-positive nuclei staining is expressed
as the percentage of the total nuclei counted from 2 MZ cell layers obtained for each rat. The data are shown as means  SE of 4 animals/group, with data being
analyzed using the ANOVA-Tukey test.
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complex regulatory network in the stem fate choice process
(4, 43).
A singular subcellular distribution of Sox2 expression was
observed at COP and in the middle of the gestation, which was
localized more frequently in the nuclear than in the cytoplas-
mic compartment of MZ cells. The nuclear Sox2 expression
has been related to its role as gatekeeper of the pluripotency in
embryonic and adult SC (25, 46), whereas the exclusion of
Sox2 from the nucleus by nucleocytoplasmic shuttling, for
instance, is associated with the inhibition of its activity, thereby
allowing pituitary endocrine differentiation (17). In the current
study, the mRNA of the progenitor marker Sox9 showed an
increase at d15G and active lactancy, whereas its protein levels
rose at d1L. These fluctuations detected allowed us to hypoth-
esize that Sox9 could have participated during the activation of
the SC/P niche during gestation and lactancy through the
expansion of a progenitor cell population, thus acquiring a
transitional state before choosing a definitive fate.
The expression of the organ-specific factors Prop1 and Pit-1
may reveal a cell population at a committed precursor stage in
the course of differentiation to a specific cell type (54). The
mRNA levels of these markers displayed an interesting in-
crease in the MZ and AP in AT and in the early and active
lactancy groups. In particular, Prop1 exhibited a noticeable
mRNA increment at d1L in the MZ, whereas Pit-1 showed a
similar behavior at in AP. We also analyzed the relationship
between PROP1/Pit-1 in MZ vs. AP. In MZ, the PROP1
expression was greater than Pit-1 in AT and d1L, whereas this
relation was inverted in AP for the same groups. It is possible
that the low PROP1 mRNA levels compared with the high
Pit-1 levels in AP could have been related to the initiation of
differentiation programs similar to those occurring during em-
bryonic development of the hormonal cells (7, 57, 59).
Accumulating evidence has indicated a marked plastic ad-
aptation (21) of the adult pituitary gland occurring mainly in
response to hormonal stimulus in the reproductive states (45).
Classically, during gestation and lactancy, an increase in the
adenohypophysial cell proliferation has been described in hu-
mans and rats (1, 24). However, in recent years, it has been
shown that the trophic activity under basal conditions as well
as in response to hormonal stimuli also occurs in cells that are
not hormonally active (36). To date, however, there are no
studies that have investigated a differential cell proliferation in
the MZ or AP cells during remodeling of the hormonal cells.
Therefore, we performed an analysis of the incorporation of
BrdU in MZ and AP cells. A remarkable fluctuation in BrdU
Fig. 8. Cell proliferation in AP cells at gestation and lactation pituitaries. A–E: representative light microscope photomicrographs of BrdU-positive cells observed
in rats at COP (A), d5G (B), AT (C), d1L (D), and d4L (E). Arrows highlight selected cells that are positive for BrdU in AP zone. Original magnification, 400.
F: The BrdU incorporation in AP increases at d5G (*P 
 0.05, d5G vs. COP) and at early lactancy (P 
 0.05, d1L vs. AT), after which a reduction at
d4L is observed (ŒP 
 0.05, d4L vs. AT). The BrdU-positive nuclei staining is expressed as the percentage of the total nuclei counted from a total of
5,000 AP cells obtained from randomized samples for each rat. The data are shown as means  SE of 4 animals/group, with data being evaluated using
the ANOVA-Tukey test.
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uptake was observed in MZ cells, showing a significant rise at
AT. A different pattern of BrdU uptake was described in AP,
with an increase being detected at early lactancy followed by
decrease at d4L in the number of BrdU-positive cells in both
the MZ and AP zones. Considering the upregulation of SC
markers and the increase in cell proliferation in the MZ of the
AT group, an expansion of the SC niche in the MZ at term of
gestation may be proposed. On analyzing the proliferating cells
that expressed the GFRa2 marker in the MZ at term of
gestation, a significant increase in BrdU-GFRa2 cells was
observed in the MZ of the AT group, indicating that the
pituitary SC that were in a rest condition may have reentered
the cell cycle to supply the physiological demands, as reported
previously in other adult tissues (52). In a recent report using
the lineage-tracing experiment, it was demonstrated that pitu-
itary stem cells are derived from the embryonic Rathke’s pouch
progenitors and that they continue to proliferate and differen-
tiate to contribute to postnatal pituitary growth (60). For the
progenitor marker, we compared the Sox9-proliferating cells in
the MZ vs. AP of the d1L group, which described the highest
cell proliferation values and observed that the positive cells
were significantly greater in the AP. These findings suggest an
expansion of the SC pituitary MZ niche at the end of gestation,
which may then be mobilized to the AP region as Sox9
progenitor cells, thus making it possible to differentiate in
specific types of endocrine cells at early lactancy.
In conclusion, in the present study, we detected oscillatory
patterns in the mRNA and protein levels of the SC/P markers
in combination with a remarkable fluctuation in the cell pro-
liferation rate in the MZ during the gestation and lactancy.
These data are indicative of a pituitary SC/P niche contribution
to supply the demand for new endocrine cells in the reproduc-
Fig. 9. Double immunofluorescence for BrdU with GFRa2 or Sox9. A: coimmunostaining of BrdU and GFRa2 in the MZ of the COP group. Original
magnification, 200. B: *BrdU-positive MZ cells showed GFRa2 expression from AT pituitaries. Original magnification, 600. C: an increase in
BrdU-GFRa2 MZ cells occurred in the AT group (*P 
 0.05, AT vs. COP). BrdU-GFRa2 cells were expressed as the percentage of total BrdU-positive cells
that comprised the 1st and 2nd layers of the MZ obtained from random samples for each rat. Data are shown as means  SE of 3 animals/group (t-test). D:
*BrdU-Sox9 cells in the MZ and AP from the d1L pituitary group. Dotted line indicates the limit of the MZ and AP. Original magnification, 200. E:
BrdU-Sox9 cells showed a significant increase in AP in the d1L group (*P 
 0.05, AP vs. MZ). BrdU-Sox9 cells were expressed as the percentage of total
BrdU-positive cells of the 1st and 2nd layers of MZ and also as a total of 1,000 AP cells obtained from random samples for each rat. Data are shown as means 
SE of 3 animals/group (t-test). F: *in the AP, some scarce cells coexpressed Sox9 and prolactin (PRL; see inset) from the early lactancy pituitaries. Original
magnification, 400.
E377SC/P CELL MARKER EXPRESSION DURING GESTATION AND LACTANCY
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00077.2016 • www.ajpendo.org






tive states studied. A future better understanding of this mech-
anism may provide significant insights into pituitary SC/P fate
choice and also help to shed light on the pituitary plasticity
displayed in the physiological environment.
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